The association between sodium–glucose cotransporter 2 inhibitors and contrast-associated acute kidney injury in patients with type 2 diabetes undergoing angiography: a propensity-matched study

• Published in: European journal of medical research Vol. 29; no. 1; pp. 621 - 11
• Main Authors: Yang, Hao, Yang, Lili, Jardine, Meg J., Arnott, Clare, Neuen, Brendon L., Xu, Kexi, Zhao, Xiaohui, Qian, Dehui, Cui, Bin, Qiu, Youzhu, Huang, Yuli, Yu, Jie, Wang, Jiang, Yu, Shiyong, Tan, Hu, Huang, Lan, Li, Jing-Wei, Jin, Jun
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 24.12.2024; BioMed Central; BMC
• Subjects: Acute Kidney Injury - chemically induced; Aged; Analysis; Angiography; Care and treatment; China - epidemiology; Complications and side effects; Contrast Media - adverse effects; Contrast-associated acute kidney injury; Coronary angiography; Coronary Angiography - adverse effects; Coronary Angiography - methods; Creatinine - blood; Dapagliflozin; Dextrose; Diabetes mellitus; Diabetes Mellitus, Type 2 - complications; Diabetes Mellitus, Type 2 - drug therapy; Diabetics; Female; Glucose; Humans; Incidence; Male; Middle Aged; Percutaneous coronary intervention; Percutaneous Coronary Intervention - adverse effects; Percutaneous Coronary Intervention - methods; Propensity Score; Retrospective Studies; Sodium-Glucose Transporter 2 Inhibitors - adverse effects; Sodium-Glucose Transporter 2 Inhibitors - therapeutic use; Sodium–glucose cotransporter 2 inhibitor; Transluminal angioplasty; Type 2 diabetes; China; California; Coronary angiography; Contrast-associated acute kidney injury; Percutaneous coronary intervention; Diabetes mellitus; Sodium–glucose cotransporter 2 inhibitor

Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have been proven to prevent decline in kidney function and failure. Whether SGLT2i affect the risk of contrast-associated acute kidney injury (CA-AKI) remains uncertain. Use of SGLT2i was assessed in consecutive diabetics undergoing coronary angiogr...